AVITA Medical (RCEL) Gains from Investment Securities (2019 - 2025)
Historic Gains from Investment Securities for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$617000.0.
- AVITA Medical's Gains from Investment Securities fell 19167.9% to -$617000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$322000.0, marking a year-over-year decrease of 12086.84%. This contributed to the annual value of -$2.2 million for FY2025, which is 89890.51% down from last year.
- According to the latest figures from Q4 2025, AVITA Medical's Gains from Investment Securities is -$617000.0, which was down 19167.9% from $5.1 million recorded in Q3 2025.
- AVITA Medical's Gains from Investment Securities' 5-year high stood at $5.1 million during Q2 2025, with a 5-year trough of -$617000.0 in Q4 2025.
- Its 5-year average for Gains from Investment Securities is $1.3 million, with a median of $673000.0 in 2024.
- Per our database at Business Quant, AVITA Medical's Gains from Investment Securities surged by 5290000.0% in 2021 and then plummeted by 19167.9% in 2025.
- AVITA Medical's Gains from Investment Securities (Quarter) stood at $1.8 million in 2021, then plummeted by 119.41% to -$341000.0 in 2022, then surged by 281.52% to $619000.0 in 2023, then rose by 8.72% to $673000.0 in 2024, then tumbled by 191.68% to -$617000.0 in 2025.
- Its last three reported values are -$617000.0 in Q4 2025, $5.1 million for Q3 2025, and $5.1 million during Q2 2025.